Bioness, Valenica, Calif, has been presented with the Frost & Sullivan 2015 Market Leadership Award in Functional Electrical Stimulation (FES) for Walking. A news release from the company notes that Bioness’ suite of lower extremity FES devices, including the L300 Foot Drop System and the L300 Plus System, are built to serve patients with central nervous system pathologies, such as stroke, multiple sclerosis, spinal cord injury, traumatic brain injury, and cerebral palsy.
Todd Cushman, Bioness president and CEO, calls the recognition by Frost & Sullivan an “important step to increasing technology awareness and accessibility to the many thousands of people who can benefit from Bioness technologies.”
Cushman adds in the release that it is gratifying to know the award is based not only on the company’s technology and its capacity to “deliver significant functional benefits, but on direct feedback from our customers.”
According to the release, Bioness was recognized in the Frost & Sullivan Market Leadership Report for driving significant value in three primary areas, which appear below.
The first area included improved electrodes that increase repeatability and reduce set-up time; the second, adaptable gait detection technology delivered through proprietary algorithms; and the third, expanding availability outside the rehabilitation setting to individuals in the community limited by lower extremity paralysis.
For more information about Bioness, visit
Source: Bioness